Ebola virus disease
ST Jacob, I Crozier, WA Fischer, A Hewlett… - Nature reviews Disease …, 2020 - nature.com
Ebola virus disease (EVD) is a severe and frequently lethal disease caused by Ebola virus
(EBOV). EVD outbreaks typically start from a single case of probable zoonotic transmission …
(EBOV). EVD outbreaks typically start from a single case of probable zoonotic transmission …
Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China
L Yang, Z Wang - European journal of medicinal chemistry, 2023 - Elsevier
The ongoing COVID-19 pandemic has resulted in millions of deaths globally, highlighting
the need to develop potent prophylactic and therapeutic strategies against SARS-CoV-2 …
the need to develop potent prophylactic and therapeutic strategies against SARS-CoV-2 …
Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient
JH Baang, C Smith, C Mirabelli… - The Journal of …, 2021 - academic.oup.com
We describe a case of chronic coronavirus disease 2019 (COVID-19) in a patient with
lymphoma and associated B-cell immunodeficiency. Viral cultures and sequence analysis …
lymphoma and associated B-cell immunodeficiency. Viral cultures and sequence analysis …
[HTML][HTML] Remdesivir as a possible therapeutic option for the COVID-19
JA Al-Tawfiq, AH Al-Homoud… - Travel medicine and …, 2020 - ncbi.nlm.nih.gov
In a recent review article, there were multiple preventive measures that were proposed for
the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)[1]. Since 2002, we had …
the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)[1]. Since 2002, we had …
Coronavirus disease 2019 treatment: a review of early and emerging options
EK McCreary, JM Pogue - Open forum infectious diseases, 2020 - academic.oup.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …
Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review
JM Sanders, ML Monogue, TZ Jodlowski, JB Cutrell - Jama, 2020 - jamanetwork.com
Importance The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
E De Wit, F Feldmann, J Cronin… - Proceedings of the …, 2020 - National Acad Sciences
The continued emergence of Middle East Respiratory Syndrome (MERS) cases with a high
case fatality rate stresses the need for the availability of effective antiviral treatments …
case fatality rate stresses the need for the availability of effective antiviral treatments …
Arguments in favour of remdesivir for treating SARS-CoV-2 infections
Since the end of 2019, an increasing number of cases of pneumonia were reported in
Wuhan, followed by other cities and provinces in China and many other countries …
Wuhan, followed by other cities and provinces in China and many other countries …
COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask …
Scientists across disciplines, policymakers, and journalists have voiced frustration at the
unprecedented polarization and misinformation around coronavirus disease 2019 (COVID …
unprecedented polarization and misinformation around coronavirus disease 2019 (COVID …
Targeting SARS-CoV-2 proteases and polymerase for COVID-19 treatment: state of the art and future opportunities
The newly emerged coronavirus, called SARS-CoV-2, is the causing pathogen of pandemic
COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is …
COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is …